US2005148953A1PendingUtilityA1
Infusion catheter
Priority: Jun 24, 1999Filed: Jan 10, 2005Published: Jul 7, 2005
Est. expiryJun 24, 2019(expired)· nominal 20-yr term from priority
Inventors:Richard Eustis Fulton, Iii
A61B 17/22012A61B 17/320725A61B 17/320758A61B 2017/00685A61B 2017/22034A61B 2017/22067A61B 2017/22084A61B 2017/320775A61M 25/007A61M 25/10A61M 2025/1052A61M 2025/1084
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device and method to dissolve or eliminate blood clots from a patient relies upon a non-rapid moving mechanism to physically dissolve clots without damaging endothelium of the arteries and veins of a patient. In one embodiment, in addition to mechanical agitation of a clot, a thrombolytic agent is administered simultaneously with such agitation. Preferably, intermittent agitation is utilized over a prolonged period of time to effectuate clot removal.
Claims
exact text as granted — not AI-modified1 . A pharmomechanical device, comprising:
a catheter having a spiral shape throughout its length that is substantially incapable of damaging an endothelium of a vascular structure, said catheter rotating between 30 rpm and 600 rpm once it is inserted inside a patient, said catheter increasing the surface area of a clot in said vascular structure such that said clot can be dissolved by a lytic agent; and means for providing a rotational motion to said catheter.
2 . The device as set forth in claim 1 , further comprising a pump that delivers lytic agent in pulse waves, said pulse waves causing an intermittent mechanical motion of said catheter, and wherein an intermittent mechanical motion of the catheter is caused by the delivery of said lytic agent.
3 . The device as set forth in claim 2 , wherein said pump is programmed to deliver said lytic agent at a desired frequency or duration.
4 . The pharmomechanical device of claim 1 , wherein said catheter rotates at less than about 55 rpm.
5 . A pharmomechanical device, comprising:
a catheter having a length and having a spiral shape throughout a substantial portion of said length, said catheter being substantially incapable of damaging an endothelium of a vascular structure, said catheter rotating at less than about 600 rpm once it is inserted inside a patient to increase the surface area of a clot in said vascular structure; and a means for rotating said catheter.
6 . The device as set forth in claim 5 , further comprising a pump that delivers lytic agent in pulse waves, said pulse waves causing an intermittent mechanical motion of said catheter, and wherein an intermittent mechanical motion of the catheter is caused by the delivery of said lytic agent.
7 . The device as set forth in claim 6 , wherein said pump is programmed to deliver said lytic agent at a desired frequency or duration.
8 . The pharmomechanical device of claim 5 , wherein said catheter rotates at less than about 55 rpm.
9 . A pharmomechanical device, comprising:
a catheter having a spiral shape throughout substantially its entire length that is substantially incapable of damaging an endothelium of a vascular structure, said catheter rotating less than about 55 rpm once it is inserted inside a patient, said catheter increasing the surface area of a clot in said vascular structure such that said clot can be dissolved by a lytic agent; and a pump that delivers lytic agent in pulse waves, said pulse waves causing an intermittent mechanical motion of said catheter.
10 . The device as set forth in claim 9 , further comprising a pump that delivers lytic agent in pulse waves, said pulse waves causing an intermittent mechanical motion of said catheter, and wherein an intermittent mechanical motion of the catheter is caused by the delivery of said lytic agent.
11 . The device as set forth in claim 10 , wherein said pump is programmed to deliver said lytic agent at a desired frequency or duration.
12 . The pharmomechanical device of claim 9 , wherein said catheter rotates at less than about 55 rpm.Join the waitlist — get patent alerts
Track US2005148953A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.